Research published in The FEBS Journal may help overcome challenges to the treatment of malaria—a tropical disease caused by infection of red blood cells with Plasmodium parasites, which are transmitted through infected mosquito bites. The research is based on a strategy that targets an enzyme specific to the parasite, falcipain-2 (FP2), which is essential for parasite survival and growth within the host.
From Biology News - Evolution, Cell theory, Gene theory, Microbiology, Biotechnology via This RSS Feed.
You must log in or # to comment.


